Engineering proteins faster: Google Alum’s AI startup Cradle raises $24 mn for biotech work | Tech News

Engineering proteins faster: Google Alum’s AI startup Cradle raises $24 mn for biotech work

European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists design and engineer proteins faster and more cost-effectively.

| Updated on: Nov 29 2023, 10:51 IST
Google Pay launches 5 new lending products for consumers and merchants in India; Know them all
European biotech startup
1/6 At the Google for India 2023 event, the tech giant announced multiple India-centric announcements, ranging from AI, online safety, accessibility to small businesses, to Pixel phones. Google also launched 5 different lending products in India for both consumers and merchants by collaborating with banks and NBFCs. These credit services are aimed at addressing the credit gap in India. (Shaurya/HT Tech)
image caption
2/6 Earlier this year, Google Pay added the facility to add Rupay credit cards to the app, and using them to seamlessly make payments via UPI.  Extending this functionality further, in collaboration with its PSP ICICI Bank, users can now avail credit lines from banks on UPI, and use it to make payments via Google Pay in the same way that they would with a UPI payment.  (Shaurya/HT Tech)
image caption
3/6 Personal loans have been available on Google Pay for the last few years in collaboration with its partner DMI Finance. This portfolio is expanding with Axis Bank making its personal loans available on Google Pay, with more partners to follow shortly.  (Shaurya/HT Tech)
image caption
4/6 Expanding the portfolio of merchant loans: On the merchant side, Google announced its new partnership with ICICI Bank and seamless repeat loans powered by Indifi.  (Shaurya/HT Tech)
image caption
5/6 Merchants often require smaller ticket loans and simpler repayment options. To address this, Google Pay is enabling on its platform, sachet loans in collaboration with DMI Finance. These start as low as Rs. 15000 and can be repaid with easy repayment options starting at just Rs. 111. This offering is aimed at bringing ease and convenience to SMBs.  (Shaurya/HT Tech)
image caption
6/6 Google Pay is enabling a credit line for merchants in partnership with ePayLater. This product will help solve the working capital requirements of merchants. Merchants can use this line across all online and offline distributors to buy their stock and supplies and grow their business.  (Shaurya/HT Tech)
European biotech startup
icon View all Images
European biotech startup Cradle raised $24 million in a Series A round led by Index Ventures. (REUTERS)

European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists design and engineer proteins faster and more cost-effectively. Index Ventures led the Series A round, joined by Kindred Capital, Chris Gibson, the co-founder of Recursion Pharmaceuticals Inc., and Tom Glocer, the former chief executive officer of Thomson Reuters Corp. and a Merck & Co. board member, Cradle said Tuesday. The startup has raised a total of $33 million so far, including a seed round last year.

Cradle harnesses generative artificial intelligence to help create proteins beyond what exists in nature. It's working on more than a dozen projects to engineer a wide range of protein sequences and 3D structures for enzymes, vaccines, lab-grown food and other materials.

Founded in 2021, the startup's customers include Johnson & Johnson, Novozymes A/S and Twist Bioscience Corp. It has offices in Delft, Netherlands, as well as Zurich.

Generative AI, made famous by OpenAI's ChatGPT chatbot, has the potential to transform drug development. Cradle's proprietary generative AI, trained on billions of protein sequences as well as data generated in its own laboratories, helps biologists design improved proteins and speed up R&D. 

“Results show that Cradle's technology leads to fewer, yet more successful experiments, making progress faster,” said Stef van Grieken, its co-founder and chief executive officer, who previously led product development at Google Brain.

Generative AI capabilities could improve the chances of solving protein engineering challenges that can't be handled with existing tools, Cradle said. For instance, biopharma companies spend an average of $22 million and 42 months of research to get a single potential product ready for clinical tests. Even then, only about a third of these progress to clinical trials, according to Cradle.

“It's still very early days in this field, we are at maybe GPT 0.5,” Van Grieken said in a video interview. “So many cool startups are starting to build at the intersection of science and AI.”

Cradle's web-based software makes it easier for biotech companies to make their data available for use in generative AI and machine learning tools. The company has about 20 machine learning engineers and biotech researchers, and it plans to use the fresh capital to expand its team as well as build additional engineering and lab facilities.

“The application of AI in biology will be transformational,” said Sofia Dolfe, a partner at Index Ventures.

Catch all the Latest Tech News, Mobile News, Laptop News, Gaming news, Wearables News , How To News, also keep up with us on Whatsapp channel,Twitter, Facebook, Google News, and Instagram. For our latest videos, subscribe to our YouTube channel.

First Published Date: 28 Nov, 22:04 IST